{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:28:11Z","timestamp":1793633291764,"version":"4.5.1"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81960221"],"award-info":[{"award-number":["81960221"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260249"],"award-info":[{"award-number":["82260249"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020205","name":"Jiangxi Province Health Commission","doi-asserted-by":"publisher","award":["202311506"],"award-info":[{"award-number":["202311506"]}],"id":[{"id":"10.13039\/501100020205","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010251","name":"Youth Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20224BAB216045"],"award-info":[{"award-number":["20224BAB216045"]}],"id":[{"id":"10.13039\/501100010251","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.thromres.2026.109613","type":"journal-article","created":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T15:40:24Z","timestamp":1770565224000},"page":"109613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mechanisms of cerebral venous sinus thrombosis due to essential thrombocythemia: Current status and future perspectives"],"prefix":"10.1016","volume":"259","author":[{"given":"Zexun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.thromres.2026.109613_bb0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41408-020-0290-9","article-title":"The new WHO classification for essential thrombocythemia calls for revision of available evidences","volume":"10","author":"Barbui","year":"2020","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.thromres.2026.109613_bb0010","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1055\/s-0040-1718873","article-title":"Platelet function and turnover in essential thrombocythemia: a systematic review","volume":"47","author":"Kvernberg","year":"2021","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2026.109613_bb0015","doi-asserted-by":"crossref","DOI":"10.1007\/s11239-025-03204-0","article-title":"Enhanced GPVI-dependent platelet pro-adhesive activity in patients with advanced coronary artery disease","author":"Heydari","year":"2025","journal-title":"J. Thromb. Thrombolysis"},{"issue":"1","key":"10.1016\/j.thromres.2026.109613_bb0020","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11239-022-02729-y","article-title":"Stable CAD patients show higher levels of platelet-borne TGF-\u03b21 associated with a superior pro-inflammatory state than the pro-aggregatory status; evidence highlighting the importance of platelet-derived TGF-\u03b21 in atherosclerosis","volume":"55","author":"Ahmadi","year":"2023","journal-title":"J. Thromb. Thrombolysis"},{"issue":"1","key":"10.1016\/j.thromres.2026.109613_bb0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-25196-w","article-title":"A design for an efficient functional panel that determines platelet exhaustion levels to differentiate responder and non-responder ITP patients","volume":"15","author":"Heidari","year":"2025","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.thromres.2026.109613_bb0030","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood-2016-10-695940","article-title":"Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms","volume":"129","author":"Vainchenker","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2026.109613_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100714","article-title":"Current management strategies for polycythemia vera and essential thrombocythemia","volume":"42","author":"Guglielmelli","year":"2020","journal-title":"Blood Rev."},{"issue":"12","key":"10.1016\/j.thromres.2026.109613_bb0040","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/ajh.26008","article-title":"Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management","volume":"95","author":"Tefferi","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.thromres.2026.109613_bb0045","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/leu.2015.360","article-title":"Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria","volume":"30","author":"Gisslinger","year":"2016","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.thromres.2026.109613_bb0050","doi-asserted-by":"crossref","DOI":"10.1172\/JCI172256","article-title":"Multiomic profiling reveals metabolic alterations mediating aberrant platelet activity and inflammation in myeloproliferative neoplasms","volume":"134","author":"He","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2026.109613_bb0055","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.thromres.2022.03.022","article-title":"Platelet-leukocyte crosstalk in COVID-19: how might the reciprocal links between thrombotic events and inflammatory state affect treatment strategies and disease prognosis?","volume":"213","author":"Ghasemzadeh","year":"2022","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2026.109613_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18802-0","article-title":"Platelet-derived microparticles enhance megakaryocyte differentiation and platelet generation via miR-1915-3p","volume":"11","author":"Qu","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.thromres.2026.109613_bb0065","article-title":"Platelet-derived microparticles and their cargos: the past, present and future","volume":"19","author":"Guo","year":"2024","journal-title":"Asian J. Pharm. Sci."},{"issue":"15","key":"10.1016\/j.thromres.2026.109613_bb0070","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1182\/bloodadvances.2018022392","article-title":"Dichloroacetate, an inhibitor of pyruvate dehydrogenase kinases, inhibits platelet aggregation and arterial thrombosis","volume":"2","author":"Nayak","year":"2018","journal-title":"Blood Adv."},{"issue":"8","key":"10.1016\/j.thromres.2026.109613_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135463","article-title":"Microarray and proteomic analyses of myeloproliferative neoplasms with a highlight on the mTOR signaling pathway","volume":"10","author":"\u010coki\u0107","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.thromres.2026.109613_bb0080","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12967-021-02756-y","article-title":"mTOR regulates GPVI-mediated platelet activation","volume":"19","author":"Wang","year":"2021","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.thromres.2026.109613_bb0085","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/jth.14210","article-title":"Cerebral venous sinus thrombosis","volume":"16","author":"Capecchi","year":"2018","journal-title":"J Thromb Haemost JTH."},{"issue":"3","key":"10.1016\/j.thromres.2026.109613_bb0090","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","article-title":"Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies","volume":"73","author":"Xu","year":"2021","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.thromres.2026.109613_bb0095","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1089\/ten.teb.2021.0148","article-title":"Strategies for improving endothelial cell adhesion to blood-contacting medical devices","volume":"28","author":"Wolfe","year":"2022","journal-title":"Tissue Eng. Part B Rev."},{"issue":"1","key":"10.1016\/j.thromres.2026.109613_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-022-00845-z","article-title":"Neutrophil extracellular traps promote thrombogenicity in cerebral venous sinus thrombosis","volume":"12","author":"Jin","year":"2022","journal-title":"Cell Biosci."},{"key":"10.1016\/j.thromres.2026.109613_bb0105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.thromres.2024.03.005","article-title":"Platelet factor 4 promotes deep venous thrombosis by regulating the formation of neutrophil extracellular traps","volume":"237","author":"Li","year":"2024","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2026.109613_bb0110","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/bjh.20216","article-title":"Anti-PF4 disorders: pathogenesis, diagnosis and treatment","volume":"207","author":"Preece","year":"2025","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2026.109613_bb0115","article-title":"Characteristics and management of autoimmune disease-associated cerebral venous sinus thrombosis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.thromres.2026.109613_bb0120","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3390\/jcm12031078","article-title":"Proteomic-based platelet activation-associated protein SELP may be a novel biomarker for coagulation and prognostic in essential thrombocythemia","volume":"12","author":"Wang","year":"2023","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.thromres.2026.109613_bb0125","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3389\/fimmu.2019.01373","article-title":"Platelets as mediators of Thromboinflammation in chronic myeloproliferative neoplasms","author":"Marin Oyarz\u00fan","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.thromres.2026.109613_bb0130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/cvr\/cvad017","article-title":"Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice","volume":"119","author":"Z\u0105bczyk","year":"2023","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.thromres.2026.109613_bb0135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ajh.25303","article-title":"Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management","volume":"94","author":"Tefferi","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.thromres.2026.109613_bb0140","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/jmri.28177","article-title":"Advances in the understanding of the complex role of venous sinus stenosis in idiopathic intracranial hypertension","volume":"56","author":"Zhao","year":"2022","journal-title":"J Magn Reson Imaging."},{"issue":"23","key":"10.1016\/j.thromres.2026.109613_bb0145","article-title":"Novel movable typing for personalized vein-chips in large scale: recapitulate patient-specific Virchow\u2019s triad and its contribution to cerebral venous sinus thrombosis","volume":"33","author":"Zhao","year":"2023","journal-title":"Adv. Funct. Mater."},{"issue":"7","key":"10.1016\/j.thromres.2026.109613_bb0150","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1007\/s00415-024-12225-3","article-title":"Endothelial receptor proteins in acute venous thrombosis and delayed thrombus resolution in cerebral sinus vein thrombosis","volume":"271","author":"Kellermair","year":"2024","journal-title":"J. Neurol."},{"issue":"12","key":"10.1016\/j.thromres.2026.109613_bb0155","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1182\/bloodadvances.2023011692","article-title":"Exacerbation of thromboinflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosis","volume":"8","author":"Bourrienne","year":"2024","journal-title":"Blood Adv."},{"issue":"12","key":"10.1016\/j.thromres.2026.109613_bb0160","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1182\/bloodadvances.2024012977","article-title":"Blood cell JAKtivation aggravates cerebral venous thrombosis","volume":"8","author":"Reeves","year":"2024","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.thromres.2026.109613_bb0165","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS."},{"issue":"2","key":"10.1016\/j.thromres.2026.109613_bb0170","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s12028-019-00695-7","article-title":"Multimodal regional brain monitoring of tissue ischemia in severe cerebral venous sinus thrombosis","volume":"31","author":"Simonin","year":"2019","journal-title":"Neurocrit. Care."},{"key":"10.1016\/j.thromres.2026.109613_bb0175","article-title":"Evolution of neutrophil extracellular traps in the pathology of stroke","author":"Ning","year":"2025","journal-title":"Neural Regen. Res."},{"issue":"2","key":"10.1016\/j.thromres.2026.109613_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12682","article-title":"Epidemiology of cerebral venous sinus thrombosis and cerebral venous sinus thrombosis with thrombocytopenia in the United States, 2018 and 2019","volume":"6","author":"Payne","year":"2022","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109613_bb0185","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2147\/NDT.S294712","article-title":"Clinical characteristics and management of cerebral venous sinus thrombosis in patients with essential thrombocythemia","volume":"17","author":"Jiao","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"11","key":"10.1016\/j.thromres.2026.109613_bb0190","doi-asserted-by":"crossref","first-page":"E200","DOI":"10.1002\/ajh.23809","article-title":"Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European leukemia net study","volume":"89","author":"Martinelli","year":"2014","journal-title":"Am. J. Hematol."},{"issue":"12","key":"10.1016\/j.thromres.2026.109613_bb0195","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/ajh.26336","article-title":"Cerebral venous thrombosis and myeloproliferative neoplasms: a three-center study of 74 consecutive cases","volume":"96","author":"Gangat","year":"2021","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.thromres.2026.109613_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-022-00646-0","article-title":"JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes","volume":"12","author":"Sureau","year":"2022","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.thromres.2026.109613_bb0205","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40364-021-00298-5","article-title":"Emerging agents and regimens for polycythemia vera and essential thrombocythemia","volume":"9","author":"Shallis","year":"2021","journal-title":"Biomark. Res."},{"issue":"42","key":"10.1016\/j.thromres.2026.109613_bb0210","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1093\/eurheartj\/ehab447","article-title":"The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms","volume":"42","author":"Baldini","year":"2021","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.thromres.2026.109613_bb0215","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3324\/haematol.2012.082560","article-title":"Increased reactive oxygen species production and p47phox phosphorylation in neutrophils from myeloproliferative disorders patients with JAK2 (V617F) mutation","volume":"98","author":"Hurtado-Nedelec","year":"2013","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.thromres.2026.109613_bb0220","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1083\/jcb.201006052","article-title":"Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps","volume":"191","author":"Papayannopoulos","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.thromres.2026.109613_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/srep18302","article-title":"Classical ROS-dependent and early\/rapid ROS-independent release of neutrophil extracellular traps triggered by Leishmania parasites","volume":"5","author":"Rochael","year":"2015","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.thromres.2026.109613_bb0230","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1083\/jcb.200606027","article-title":"Novel cell death program leads to neutrophil extracellular traps","volume":"176","author":"Fuchs","year":"2007","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.thromres.2026.109613_bb0235","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.1002\/ajh.27148","article-title":"Comparative thrombotic risk associated with CALR1, CALR2, and JAK2 V617F mutations in essential thrombocythemia","volume":"99","author":"Neupane","year":"2024","journal-title":"Am. J. Hematol."},{"issue":"7","key":"10.1016\/j.thromres.2026.109613_bb0240","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.3390\/ijms22073371","article-title":"The contemporary approach to CALR-positive myeloproliferative neoplasms","volume":"22","author":"Bel\u010di\u010d Miki\u010d","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"31","key":"10.1016\/j.thromres.2026.109613_bb0245","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1038\/s41388-020-1368-3","article-title":"Different impact of calreticulin mutations on human hematopoiesis in myeloproliferative neoplasms","volume":"39","author":"El-Khoury","year":"2020","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.thromres.2026.109613_bb0250","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13045-021-01116-z","article-title":"Molecular pathogenesis of the myeloproliferative neoplasms","volume":"14","author":"Greenfield","year":"2021","journal-title":"J Hematol OncolJ Hematol Oncol."},{"issue":"10024","key":"10.1016\/j.thromres.2026.109613_bb0255","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0140-6736(14)62293-5","article-title":"Platelet interaction with erythrocytes and propensity to aggregation in essential thrombocythaemia","volume":"387","author":"van Rooy","year":"2016","journal-title":"Lancet Lond Engl."},{"issue":"3","key":"10.1016\/j.thromres.2026.109613_bb0260","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3390\/ijms25031417","article-title":"Red blood cell contribution to thrombosis in polycythemia vera and essential thrombocythemia","volume":"25","author":"Grenier","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.thromres.2026.109613_bb0265","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00277-018-3228-6","article-title":"Phosphatidylserine-exposing blood and endothelial cells contribute to the hypercoagulable state in essential thrombocythemia patients","volume":"97","author":"Tong","year":"2018","journal-title":"Ann. Hematol."},{"issue":"9","key":"10.1016\/j.thromres.2026.109613_bb0270","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1161\/ATVBAHA.124.321008","article-title":"Decoding endothelial MPL and JAK2V617F mutation: insight into cardiovascular dysfunction in myeloproliferative neoplasms","volume":"44","author":"Zhang","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"26","key":"10.1016\/j.thromres.2026.109613_bb0275","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1182\/blood-2014-07-587238","article-title":"The thrombopoietin receptor, MPL, is critical for development of a JAK2V617F-induced myeloproliferative neoplasm","volume":"124","author":"Sangkhae","year":"2014","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.thromres.2026.109613_bb0280","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/stem.2888","article-title":"JAK2V617F megakaryocytes promote hematopoietic stem\/progenitor cell expansion in mice through Thrombopoietin\/MPL signaling","volume":"36","author":"Zhang","year":"2018","journal-title":"Stem Cells Dayt Ohio"},{"issue":"4","key":"10.1016\/j.thromres.2026.109613_bb0285","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.stem.2021.02.026","article-title":"Hematopoietic stem cell heterogeneity is linked to the initiation and therapeutic response of myeloproliferative neoplasms","volume":"28","author":"Tong","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.thromres.2026.109613_bb0290","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s13760-022-02077-x","article-title":"Characteristics of patients with cerebral sinus venous thrombosis and JAK2 V617F mutation","volume":"123","author":"Simaan","year":"2023","journal-title":"Acta Neurol. Belg."},{"issue":"10","key":"10.1016\/j.thromres.2026.109613_bb0295","first-page":"950","article-title":"A case of essential thrombocythemia complicated with cerebral venous sinus thrombosis","volume":"12","author":"Hu","year":"2017","journal-title":"Chin J Stroke."},{"issue":"18","key":"10.1016\/j.thromres.2026.109613_bb0300","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1212\/WNL.0000000000206836","article-title":"Clinical reasoning: a 25-year-old woman with eye swelling and headache","volume":"100","author":"Hehir","year":"2023","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.thromres.2026.109613_bb0305","first-page":"1074","article-title":"Diagnosis and management of cerebral venous thrombosis due to polycythemia vera and genetic thrombophilia: case report and literature review","volume":"13","author":"Jianu","year":"2023","journal-title":"Life (Basel)."},{"issue":"5","key":"10.1016\/j.thromres.2026.109613_bb0310","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11547-016-0630-9","article-title":"Cerebral sinovenous thrombosis (CSVT) in children: what the pediatric radiologists need to know","volume":"121","author":"Carducci","year":"2016","journal-title":"Radiol Med (Torino)"},{"issue":"3","key":"10.1016\/j.thromres.2026.109613_bb0315","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11547-020-01265-0","article-title":"Does measurement of the jugular foramen diameter on MRI help to differentiate transverse sinus thrombosis from unilateral transverse sinus hypoplasia?","volume":"126","author":"Gul","year":"2021","journal-title":"Radiol Med (Torino)"},{"issue":"3","key":"10.1016\/j.thromres.2026.109613_bb0320","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1161\/STR.0000000000000456","article-title":"Diagnosis and management of cerebral venous thrombosis: a scientific statement from the American Heart Association","volume":"55","author":"Saposnik","year":"2024","journal-title":"Stroke"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2026.109613_bb0325","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1111\/jth.12945","article-title":"Cerebral venous thrombosis","volume":"13","author":"Coutinho","year":"2015","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.thromres.2026.109613_bb0330","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.thromres.2020.03.011","article-title":"Current imaging modalities for diagnosing cerebral vein thrombosis - a critical review","volume":"189","author":"van Dam","year":"2020","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.thromres.2026.109613_bb0335","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/STROKEAHA.115.011369","article-title":"Early detection and quantification of cerebral venous thrombosis by magnetic resonance black-blood thrombus imaging","volume":"47","author":"Yang","year":"2016","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.thromres.2026.109613_bb0340","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-023-01562-9","article-title":"A novel score to estimate thrombus burden and predict intracranial hypertension in cerebral venous sinus thrombosis","volume":"24","author":"Wang","year":"2023","journal-title":"J. Headache Pain"},{"issue":"2","key":"10.1016\/j.thromres.2026.109613_bb0345","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/svn-2020-000358","article-title":"Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of cerebral venous sinus thrombosis","volume":"5","author":"Fan","year":"2020","journal-title":"Stroke Vasc. Neurol."},{"issue":"2","key":"10.1016\/j.thromres.2026.109613_bb0350","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/ijs.12034","article-title":"Evaluation of plasma D-dimer plus fibrinogen in predicting acute CVST","volume":"9","author":"Meng","year":"2014","journal-title":"Int. J. Stroke"},{"issue":"12","key":"10.1016\/j.thromres.2026.109613_bb0355","doi-asserted-by":"crossref","DOI":"10.1177\/0300060520977729","article-title":"Frequency and characteristics of the JAK2 V617F mutation in 23 cerebral venous sinus thrombosis patients with thrombocytosis","volume":"48","author":"Ma","year":"2020","journal-title":"J. Int. Med. Res."},{"issue":"22","key":"10.1016\/j.thromres.2026.109613_bb0360","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMcp1816082","article-title":"Essential Thrombocythemia","volume":"381","author":"Tefferi","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.thromres.2026.109613_bb0365","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/bjh.18845","article-title":"Interferon alpha-2 treatment reduces circulating neutrophil extracellular trap levels in myeloproliferative neoplasms","volume":"202","author":"Massarenti","year":"2023","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.thromres.2026.109613_bb0370","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3324\/haematol.2022.281388","article-title":"Aspirin in essential thrombocythemia. For whom? What formulation? What regimen?","volume":"108","author":"Cattaneo","year":"2023","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.thromres.2026.109613_bb0375","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/bloodadvances.2020003628","article-title":"A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasms","volume":"5","author":"Hamuly\u00e1k","year":"2021","journal-title":"Blood Adv."},{"issue":"5","key":"10.1016\/j.thromres.2026.109613_bb0380","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1080\/00325481.2021.1880844","article-title":"Prevention of recurrent thromboembolism in myeloproliferative neoplasms: review of literature and focus on direct oral anticoagulants","volume":"133","author":"How","year":"2021","journal-title":"Postgrad. Med."},{"issue":"2","key":"10.1016\/j.thromres.2026.109613_bb0385","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/17474930211006303","article-title":"Recanalization after cerebral venous thrombosis. A randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous and dural sinus thrombosis","volume":"17","author":"Ferro","year":"2022","journal-title":"Int. J. Stroke"},{"issue":"2","key":"10.1016\/j.thromres.2026.109613_bb0390","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s11239-017-1512-2","article-title":"Dabigatran reduces thrombin-induced platelet aggregation and activation in a dose-dependent manner","volume":"44","author":"Vinholt","year":"2017","journal-title":"J. Thromb. Thrombolysis"},{"issue":"13","key":"10.1016\/j.thromres.2026.109613_bb0395","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017559","article-title":"Direct Oral anticoagulant use: a practical guide to common clinical challenges","volume":"9","author":"Chen","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"11","key":"10.1016\/j.thromres.2026.109613_bb0400","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41408-021-00566-5","article-title":"Practice patterns and outcomes of direct oral anticoagulant use in myeloproliferative neoplasm patients","volume":"11","author":"How","year":"2021","journal-title":"Blood Cancer J."},{"issue":"11","key":"10.1016\/j.thromres.2026.109613_bb0405","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1161\/STROKEAHA.123.044113","article-title":"Study of rivaroxaban for cerebral venous thrombosis: a randomized controlled feasibility trial comparing anticoagulation with rivaroxaban to standard-of-care in symptomatic cerebral venous thrombosis","volume":"54","author":"Field","year":"2023","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.thromres.2026.109613_bb0410","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00277-018-3483-6","article-title":"High risk of recurrent venous thromboembolism in BCR-ABL-negative myeloproliferative neoplasms after termination of anticoagulation","volume":"98","author":"Wille","year":"2019","journal-title":"Ann. Hematol."},{"issue":"5","key":"10.1016\/j.thromres.2026.109613_bb0415","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1111\/bjh.19403","article-title":"Essential thrombocythaemia: a contemporary approach with new drugs on the horizon","volume":"204","author":"Ferrer-Mar\u00edn","year":"2024","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.thromres.2026.109613_bb0420","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13045-020-00995-y","article-title":"Novel therapeutics in myeloproliferative neoplasms","volume":"13","author":"Venugopal","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"436","key":"10.1016\/j.thromres.2026.109613_bb0425","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan8292","article-title":"Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms","volume":"10","author":"Wolach","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.thromres.2026.109613_bb0430","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/13543784.2023.2267980","article-title":"Bomedemstat as an investigative treatment for myeloproliferative neoplasms","volume":"32","author":"Rienhoff","year":"2023","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"1","key":"10.1016\/j.thromres.2026.109613_bb0435","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78570-1","article-title":"The clinical analysis and treatment strategy of endovascular treatment for cerebral venous sinus thrombosis combined with intracerebral hemorrhage","volume":"10","author":"Guo","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.thromres.2026.109613_bb0440","first-page":"836","article-title":"Analysis of differential proteins related to platelet activation in patients with essential thrombocythemia based on label-free quantitative technology","volume":"30","author":"Li","year":"2022","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"1","key":"10.1016\/j.thromres.2026.109613_bb0445","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.thromres.2026.109613_bb0450","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/bjh.18669","article-title":"Molecular analysis of phenotypic heterogeneity in JAK2V617F-positive myeloproliferative neoplasms reveals a potential target for therapy","volume":"201","author":"Gu","year":"2023","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.thromres.2026.109613_bb0455","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1080\/08923973.2018.1536984","article-title":"XAV939, a Wnt\/\u03b2-catenin pathway modulator, has inhibitory effects on LPS-induced inflammatory response","volume":"41","author":"Jang","year":"2019","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"7","key":"10.1016\/j.thromres.2026.109613_bb0460","first-page":"806","article-title":"Randomized controlled trial of Longchai Jiangxue formula in the treatment of essential thrombocythemia","volume":"44","author":"Sun","year":"2024","journal-title":"Chin J Integr Tradit West Med."},{"issue":"7","key":"10.1016\/j.thromres.2026.109613_bb0465","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/bph.13429","article-title":"Effects of P2Y12 receptor antagonists beyond platelet inhibition--comparison of ticagrelor with thienopyridines","volume":"173","author":"Nylander","year":"2016","journal-title":"Br. J. Pharmacol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826000320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826000320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T14:47:59Z","timestamp":1793630879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384826000320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":93,"alternative-id":["S0049384826000320"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109613","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of cerebral venous sinus thrombosis due to essential thrombocythemia: Current status and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109613"}}